Medtronic is linking its implanted devices with Samsung’s phones and tablets to better monitor the effectiveness of neuromodulation technologies. (Click to view Samsung release.)
Those with implanted neurostimulators, which send electronic signals to targeted areas of the brain to block symptoms, can have a more active role in the management of their diseases. Parkinson’s, essential tremor and dystonia patients will hopefully benefit from the initiative.
Data from the devices will be sent to a patient’s mobile devices, including phones, wearables and tablets, in real time. It can also be sent directly to a doctor to help them better understand patient symptoms and progress, and appropriately adjust therapies.
The two companies announces a similar partnership for the management of diabetes earlier this year.
Wearable Tech + Digital Health San Francisco – April 5, 2016 @ the Mission Bay Conference Center
NeuroTech San Francisco – April 6, 2016 @ the Misson Bay Conference Center
Wearable Tech + Digital Health NYC – June 7, 2016 @ the New York Academy of Sciences
NeuroTech NYC – June 8, 2016 @ the New York Academy of Sciences